Statute of Limitations
Louisiana: 1-year prescriptive period from discovery (La. Civ. Code art. 3492) — act immediately
1 year from BIA-ALCL diagnosis or discovery of BIOCELL injury — consult attorney immediately
Where to File in Louisiana
Louisiana has a 1-year prescriptive period for tort (delictual) actions under La. Civ. Code art. 3492. Louisiana operates under a civil law system, unlike the other 49 states, which can create unique procedural considerations. However, the substantive harm and Allergan's conduct are the same as in other states. Louisiana BIA-ALCL claimants must act immediately upon diagnosis — the 1-year window is strict. New Orleans and Baton Rouge cosmetic surgery markets placed Allergan BIOCELL products during the 2005–2019 period. Louisiana plaintiffs file in MDL 2921 in the District of New Jersey, where the federal court applies applicable state law.
Exposure in Louisiana
Source: La. Civ. Code art. 3492
Source: FDA Adverse Event Reporting System